Iran Bio Congress: A Leading Event in Iran’s Medical Biotechnology Industry

The Iran Bio Congress is one of the most prestigious scientific and industrial events in the field of medical biotechnology and related industries in Iran. Organized with the support of the Association of Manufacturers and Exporters of Medical Biotechnology Products of Iran, the Iran Food and Drug Administration, and the Vice Presidency for Science and Technology, this congress represents a valuable opportunity to present the latest achievements in life sciences and medical biotechnology.

By bringing together industry leaders, researchers, healthcare professionals, and investors, the Iran Bio Congress plays a critical role in strengthening innovation, collaboration, and commercialization within Iran’s biotechnology ecosystem.

Overview of the Fourth Iran Bio Congress

The Fourth Iran Bio Congress and Exhibition, one of the most significant specialized gatherings in the field of medical biotechnology and related industries, was held from February 4 to 6, 2025 (16–18 Bahman 1403) at the Olympic Hotel in Tehran.

The event hosted a wide range of knowledge-based companies, physicians, researchers, specialists, and investors, providing a valuable platform for the presentation of innovative technologies, knowledge exchange, and the development of scientific and commercial collaborations.

Main Focus Areas of the Congress

The key themes addressed during the Fourth Iran Bio Congress included:

• Development of advanced technologies in the medical biotechnology industry

• Introduction of the latest biotechnology-based therapeutic products and solutions

• Review of regulatory requirements and international standards in the production of biotechnology products

• Discussion on export potential and global competitiveness of Iranian biotechnology products

In addition to scientific presentations and expert panels, the congress featured a dedicated exhibition section, where active companies showcased their latest products, innovations, and technological achievements.

Highlights of Atra Zist Aray’s Participation in the Fourth Iran Bio Congress

The participation of Atra Zist Aray in the Fourth Iran Bio Congress marked a significant milestone in the development of Iran’s medical biotechnology industry. The company, previously known for producing Iranian botulinum toxin, officially unveiled two strategic products during this major industry event:

• The first domestically produced injectable hyaluronic acid powder

• Luxafill Mesogel

These products were designed to meet domestic market demand while also targeting entry into international export markets. Their development and commercialization not only reduce Iran’s reliance on imports but also strengthen the country’s position in the global biotechnology manufacturing sector.

🔹 Injectable Hyaluronic Acid Powder

A major innovation in the field of skin rejuvenation, developed using advanced manufacturing technologies and holding the necessary approvals from the Iran Food and Drug Administration. This product serves as a safe, effective, and cost-efficient alternative to imported brands.

🔹 Luxafill Mesogel

Developed based on hyaluronic acid, Luxafill Mesogel contains essential nutrients and vitamins required for healthy skin. It plays a significant role in the treatment of wrinkles, skin hydration, and overall skin rejuvenation, making it a valuable product in the aesthetic medicine market.

🔹 Entry into the Tehran Stock Exchange

One of Atra Zist Aray’s key strategic plans is listing on the Tehran Stock Exchange (TSE). This initiative will enhance the company’s economic position, increase financial transparency, and attract new investors. It will also support further product development, increased production capacity, and expansion into international markets.

Atra Zist Aray’s Future Plans Following the Iran Bio Congress

Following its successful participation in the Iran Bio Congress, Atra Zist Aray has outlined several future initiatives, including:

✔ Expansion of its biotechnology and therapeutic product portfolio
✔ Increased collaboration with research centers and universities
✔ Development of export strategies and penetration into international markets
✔ Continued investment in research and development (R&D) to drive innovation in biotechnology products
✔ Establishment of a comprehensive distribution network to improve access to products nationwide

Given Iran’s significant potential in the biotechnology sector, participation in major congresses and the unveiling of innovative products play a crucial role in enhancing the global competitiveness of Iranian biotechnology companies.

Other Key Pharmaceutical Events

Another important event in the pharmaceutical sector in which we participate is the National Pharmacist Day Congress. Be sure not to miss this page for further updates.

Publication Date: February 1, 2025 (13 Bahman 1403)